Beryl Drugs Q1 Results

  • BSE: 524606
  • NSE: -
  • ISIN: INE415H01017
  • Sector: Biotechnology & Drugs
BSE
33.10.57 (1.75%)
Volume212.00
Updated: Tue 26 Nov, 2024 | 09:07:13
NSE
This stock is not traded on NSE
Today: 33.10
33.10
52-Wk: 20.19
46.00

Q1 Results Highlights

  • Total Income
    ₹6.25 Cr.
    (110.02%)
  • Operating Profit
    ₹0.67 Cr.
    (NA%)
  • Profit After Tax
    ₹0.37 Cr.
    (NA%)
  • Operating Margin
    10.64%
    (9.88%)
Note: Comparison is on YoY basis

Quarterly - Beryl Drugs Q1 Results

*All figures in crores except per share values
Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
Total Revenue 6.256.11-%8.11-%
Selling/ General/ Admin Expenses Total 0.500.45-%0.44-%
Depreciation/ Amortization 0.280.15-%0.28-%
Other Operating Expenses Total 1.352.13-%3.01-%
Total Operating Expense 5.585.97-%7.32-%
Operating Income 0.670.14-%0.79-%
Net Income Before Taxes 0.500.06-%0.73-%
Net Income 0.370.06-%0.53-%
Diluted Normalized EPS 0.730.12-%1.05-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts